
About Revapharma Private Limited
Data last updated:
Revapharma Private Limited was a private limited company based in Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 2019.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PTC347678. Its GSTIN is 07AAJCR4986N1ZG (Delhi).
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Its last annual general meeting (AGM) was held on 31 October 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Shop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096.
The last known website on record is revapharma.in.
Company details
Contact details
Revapharma Private Limited's registered office is in Delhi, Delhi. Its website is revapharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressShop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Revapharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Revapharma Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2018-19 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Revapharma Private Limited, buy the company report.
Board of directors of Revapharma Private Limited
Revapharma has 3 former directors on record and no current directors listed.
Auditor
Revapharma Private Limited is audited by A M A A & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A M A A & ASSOCIATES | FY 2019 | 013066C |
Shareholding
The shareholding of Revapharma Private Limited is on record for FY 2019, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2019 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Revapharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Revapharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Revapharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Revapharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCR4986N1ZG | Delhi | Active | 19 Jul 2019 |
To see the full GST registrations and return filing status of Revapharma Private Limited, buy the company report.
Recent activity
Revapharma Private Limited has 3 board changes on record since 2019: 0 appointments and 3 cessations. The latest: Nizar Balan ceased to be Director on 16 Feb 2020.
Frequently asked questions
Revapharma has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Revapharma was a private limited company based in Delhi, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 26 March 2019 and is registered under CIN U24299DL2019PTC347678. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Revapharma is U24299DL2019PTC347678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Revapharma was incorporated on 26 March 2019. It is registered with the Registrar of Companies, Delhi.
Revapharma can be reached through the website revapharma.in. Its registered office is in Delhi, India.
The registered office of Revapharma is at Shop No. 304 2nd Floor Plot No. 3 L.S.C. Blk – G Kondli Gharoli Mayur Vihar Pha, Se – III, Delhi, India – 110096.
The latest financial statements of Revapharma on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 31 October 2019. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Revapharma is 07AAJCR4986N1ZG, registered in Delhi.
Revapharma operated in the pharma industry, in the drug formulation and development segment.
Nizar Balan ceased to be Director on 16 Feb 2020. Vimal Raina ceased to be Additional Director on 16 Feb 2020. Gurpreet Sandhu Singh ceased to be Director on 12 Sep 2019.

